Breaking News Instant updates and real-time market news.

TEVA

Teva

$16.91

0.27 (1.62%)

16:56
03/19/19
03/19
16:56
03/19/19
16:56

Teva initiated with a Hold at SunTrust

SunTrust analyst Gregg Gilbert initiated Teva with a Hold rating and a price target of $17, saying that while the new CEO Kare Schultz led a cost base restructuring effort and trying to turn around the U.S. generics business, those positive are likely factored into the stock price. The analyst adds that the company's recent delay in expecting to achieve its deleveraging target "may make existing holders anxious and potential holders more patient."

  • 25

    Mar

TEVA Teva
$16.91

0.27 (1.62%)

03/06/19
03/06/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. TripAdvisor (TRIP) downgraded to Underperform from Market Perform at Cowen with analyst Kevin Kopelman citing a weak start to 2019, expectations for weaker usage, and worries about younger age demos using Google (GOOG). 2. Teva (TEVA) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst David Risinger citing his belief that the stock's premium valuation largely prices in expectations for upside in the coming quarters due to cost cutting and conservative Copaxone guidance. 3. VMware (VMW) downgraded to Sell from Neutral at Goldman Sachs, while Pivotal Software (PVTL) was downgraded to Neutral from Buy. 4. Ormat Technologies (ORA) downgraded to Neutral from Overweight at JPMorgan with the firm's analyst citing a lack of catalysts for share appreciation in 2019. 5. CSX (CSX) downgraded to Hold from Buy at Stifel with analyst Michael Baudendistel saying he no longer sees a solid reason why shares should outperform the market in the next twelve months. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/07/19
UBSW
03/07/19
INITIATION
Target $22
UBSW
Buy
Teva reinstated with a Buy at UBS
UBS analyst Navin Jacob reinstated coverage of Teva Pharmaceutical with a Buy rating and $22 price target. The U.S. generic industry is on a path to recovery, Jacob tells investors in a research note, citing his firm's generic price erosion tracker data. The analyst sees 30% potential upside and views Teva's 2019 guidance as a "hiccup."
03/07/19
03/07/19
INITIATION

Fly Intel: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. Five Below (FIVE) initiated with an Outperform at Oppenheimer. 2. Teva (TEVA) reinstated with a Buy at UBS. 3. Chiasma (CHMA) initiated with an Overweight at Cantor Fitzgerald. 4. Monster Beverage (MNST) and Constellation Brands (STZ) were initiated with an Outperform at Credit Suisse, while Procter & Gamble (PG), Coca-Cola (KO), and Church & Dwight (CHD) were initiated with a Neutral, and PepsiCo (PEP), Colgate-Palmolive (CL), and Clorox (CLX) initiated with an Underperform at Credit Suisse. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
03/13/19
WELS
03/13/19
NO CHANGE
Target $68
WELS
Market Perform
Wells says generic risk, not Purdue news, bringing down Emergent shares
Wells Fargo analyst David Maris "completely" disagrees with the view that shares of Emergent BioSolutions (EBS) are weak today on news of Purdue Pharma's nalmefene injection receiving fast track designation from the FDA. Maris notes that none of his clients have raised this as a potential issue and that, as an injection, Purdue's pproduct is not comparable to Emergent's nasal naloxone. An injection is not practical for the emergency medical technician and at home market, where most of Narcan is used, Maris tells investors in a research note. For example, Amphastar (AMPH) is a leader in the injectable market, and the vast majority of its use is in the hospital setting, the analyst points out. Rather, Maris attributes the recent selloff in Emergent BioSolutions to worries about the potential introduction of a generic version of Narcan. Teva (TEVA) has had a tentative approval for generic Narcan for some time, and its 30 month stay is over today, meaning that Teva could launch at risk from this point forward, Maris writes. As of now, there is no clear indication whether Teva will launch or not, he adds. While the analyst is not expecting an at-risk Narcan launch, he believes the risk of such an event is largely reflected in the shares given today's decline. Nonetheless, Maris keeps a Market Perform rating on Emergent with a $68 price target. The stock in afternoon trading is down 9%, or $4.98, to $52.00.

TODAY'S FREE FLY STORIES

NXPI

NXP Semiconductors

$90.85

-2.79 (-2.98%)

14:45
05/23/19
05/23
14:45
05/23/19
14:45
Options
NXP Semiconductors call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 29

    May

  • 13

    Jun

FE

FirstEnergy

$42.94

0.31 (0.73%)

14:36
05/23/19
05/23
14:36
05/23/19
14:36
Periodicals
Breaking Periodicals news story on FirstEnergy »

Ohio advances bill that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HII

Huntington Ingalls

$202.83

-6.34 (-3.03%)

14:35
05/23/19
05/23
14:35
05/23/19
14:35
Hot Stocks
Huntington Ingalls VP William Ermatinger sells almost $400K in company shares »

Huntington Ingalls VP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

QRVO

Qorvo

$59.38

-0.83 (-1.38%)

14:35
05/23/19
05/23
14:35
05/23/19
14:35
Options
Qorvo put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UIS

Unisys

$9.44

-0.3 (-3.08%)

14:31
05/23/19
05/23
14:31
05/23/19
14:31
Initiation
Unisys initiated  »

Unisys initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

MAXR

Maxar Technologies

$8.20

1.05 (14.69%)

14:28
05/23/19
05/23
14:28
05/23/19
14:28
Hot Stocks
NASA confirms contract with maximum $375M value awarded to Maxar Technologies »

NASA announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BX

Blackstone

$40.84

-0.86 (-2.06%)

, PLD

Prologis

$76.02

-0.55 (-0.72%)

14:27
05/23/19
05/23
14:27
05/23/19
14:27
Periodicals
Blackstone, Prologis separately bidding for U.S. unit of GLP, WSJ says »

Blackstone (BX) and…

BX

Blackstone

$40.84

-0.86 (-2.06%)

PLD

Prologis

$76.02

-0.55 (-0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

  • 04

    Jun

  • 11

    Jun

GLNG

Golar LNG

$19.17

-0.82 (-4.10%)

14:25
05/23/19
05/23
14:25
05/23/19
14:25
Options
Golar LNG call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JPM

JPMorgan

$107.68

-3.11 (-2.81%)

14:24
05/23/19
05/23
14:24
05/23/19
14:24
Periodicals
JPMorgan severs ties with OxyContin maker Purdue Pharma, Reuters says »

JPMorgan has severed ties…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 03

    Jun

  • 11

    Jun

  • 16

    Jul

MAXR

Maxar Technologies

$8.04

0.89 (12.45%)

14:18
05/23/19
05/23
14:18
05/23/19
14:18
Hot Stocks
Breaking Hot Stocks news story on Maxar Technologies »

Maxar Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
05/23/19
05/23
14:17
05/23/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FL

Foot Locker

$53.15

-1.05 (-1.94%)

14:16
05/23/19
05/23
14:16
05/23/19
14:16
Recommendations
Foot Locker analyst commentary at Canaccord »

Canaccord says buyers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 09

    Jul

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
05/23/19
05/23
14:16
05/23/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:15
05/23/19
05/23
14:15
05/23/19
14:15
Conference/Events
Wolfe Research pharmaceuticals analyst to hold analyst/industry conference call »

Pharmaceuticals Analyst…

VXX

iPath S&P 500 VIX Short-Term Futures

$29.12

1.91 (7.02%)

14:10
05/23/19
05/23
14:10
05/23/19
14:10
Options
Bullish spread opened in VIX Short-term Futures Fund »

Bullish spread opened in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:06
05/23/19
05/23
14:06
05/23/19
14:06
Conference/Events
Wolfe Research managing director to hold an analyst/industry webinar »

Quantitative Analysis,…

MAXR

Maxar Technologies

$7.59

0.44 (6.15%)

14:06
05/23/19
05/23
14:06
05/23/19
14:06
Hot Stocks
Maxar Technologies up 17% after selection for NASA project »

Maxar Technologies shares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLUU

Glu Mobile

$8.32

-0.185 (-2.18%)

14:05
05/23/19
05/23
14:05
05/23/19
14:05
Options
Glu Mobile call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

  • 08

    Jun

  • 10

    Jun

  • 10

    Jun

  • 13

    Nov

MAXR

Maxar Technologies

$7.32

0.17 (2.38%)

14:03
05/23/19
05/23
14:03
05/23/19
14:03
Periodicals
NASA selects Maxar for first part of lunar gateway, WFTV reports »

Maxar Technologies was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BX

Blackstone

$40.90

-0.8 (-1.92%)

, PLD

Prologis

$76.22

-0.35 (-0.46%)

14:00
05/23/19
05/23
14:00
05/23/19
14:00
Periodicals
Breaking Periodicals news story on Blackstone, Prologis »

Blackstone, Prologis bid…

BX

Blackstone

$40.90

-0.8 (-1.92%)

PLD

Prologis

$76.22

-0.35 (-0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

  • 04

    Jun

  • 11

    Jun

BX

Blackstone

$40.90

-0.8 (-1.92%)

, PLD

Prologis

$76.22

-0.35 (-0.46%)

13:59
05/23/19
05/23
13:59
05/23/19
13:59
Periodicals
Breaking Periodicals news story on Blackstone, Prologis »

Blackstone, Prologis…

BX

Blackstone

$40.90

-0.8 (-1.92%)

PLD

Prologis

$76.22

-0.35 (-0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

  • 04

    Jun

  • 11

    Jun

MAXR

Maxar Technologies

$7.00

-0.15 (-2.10%)

13:56
05/23/19
05/23
13:56
05/23/19
13:56
Periodicals
Breaking Periodicals news story on Maxar Technologies »

Maxar selected by NASA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSM

TSMC

$37.86

-0.96 (-2.47%)

13:55
05/23/19
05/23
13:55
05/23/19
13:55
Options
Taiwan Semi put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BB

BlackBerry

$8.05

-0.26 (-3.13%)

13:45
05/23/19
05/23
13:45
05/23/19
13:45
Options
BlackBerry call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:45
05/23/19
05/23
13:45
05/23/19
13:45
General news
FX Action: USD-JPY »

FX Action: USD-JPY fell…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.